$7.55
4.57% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US67018T1051
Symbol
NUS

Nu Skin Enterprises, Inc. Class A Stock price

$7.55
+1.39 22.56% 1M
-5.69 42.98% 6M
-11.87 61.12% YTD
-9.12 54.71% 1Y
-38.53 83.62% 3Y
-30.98 80.40% 5Y
-34.35 81.98% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.33 4.57%
ISIN
US67018T1051
Symbol
NUS

Key metrics

Market capitalization $375.32m
Enterprise Value $639.31m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 7.05
EV/Sales (TTM) EV/Sales 0.36
P/S ratio (TTM) P/S ratio 0.21
P/B ratio (TTM) P/B ratio 0.53
Dividend yield 3.18%
Last dividend (FY24) $0.24
Revenue growth (TTM) Revenue growth -11.37%
Revenue (TTM) Revenue $1.78b
EBIT (operating result TTM) EBIT $84.05m
Free Cash Flow (TTM) Free Cash Flow $90.74m
Cash position $237.83m
EPS (TTM) EPS $-2.08
P/E forward negative
P/S forward 0.22
EV/Sales forward 0.37
Short interest 4.52%
Show more

Is Nu Skin Enterprises, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Nu Skin Enterprises, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Nu Skin Enterprises, Inc. Class A forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Nu Skin Enterprises, Inc. Class A forecast:

Hold
100%

Financial data from Nu Skin Enterprises, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,775 1,775
11% 11%
100%
- Direct Costs 520 520
17% 17%
29%
1,255 1,255
9% 9%
71%
- Selling and Administrative Expenses 1,100 1,100
5% 5%
62%
- Research and Development Expense - -
-
-
155 155
29% 29%
9%
- Depreciation and Amortization 71 71
45% 45%
4%
EBIT (Operating Income) EBIT 84 84
4% 4%
5%
Net Profit -103 -103
276% 276%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Nu Skin Enterprises, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nu Skin Enterprises, Inc. Class A Stock News

Positive
Seeking Alpha
14 days ago
Nu Skin Enterprises, Inc. demonstrates a tested business model with long-term free cash flow generation, supported by acquisitions, new products, and digital transformation. Despite recent earnings disappointments, optimistic 2025-2026 EPS growth projections and multiple revenue catalysts suggest significant upside potential in the company's valuation. The company's global market expansion, cas...
Neutral
Seeking Alpha
18 days ago
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Scott Pond - Vice President-Investor Relations Ryan Napierski - President and Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Chasen Bender - Citigroup Ashley Helgans - Jefferies Operator Thank you for standing by. My name is Prilla,...
Neutral
Business Wire
19 days ago
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter results in line with guidance. Executive Summary Q3 2024 vs. Prior-year Quarter Revenue $430.1 million; (13.8)% (3.4)% FX impact or $(16.7) million Rhyz revenue $73.1 million; 20.9% Earnings Per Share (EPS) $0.17 compared to $(0.74) or $0.56 excluding an inventory write-off Customers 831,768; (15)% ...
More Nu Skin Enterprises, Inc. Class A News

Company Profile

Nu Skin Enterprises, Inc. develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Head office United States
CEO Ryan Napierski
Employees 15,200
Founded 1984
Website www.nuskin.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today